Supernus Pharmaceuticals
SUPN
#4335
Rank
$2.78 B
Marketcap
$48.05
Share price
1.35%
Change (1 day)
49.83%
Change (1 year)

Supernus Pharmaceuticals (SUPN) - Net assets

Net assets on the balance sheet as of March 2026 : $1.07 Billion USD

According to Supernus Pharmaceuticals 's latest financial reports the company has $1.07 Billion USD in net assets.
A companyโ€™s net assets is the sum of its assets minus the sum of its liabilities.

Supernus Pharmaceuticals - Net assets on balance sheet (from 2009 to 2026)

Net assets by year

Year Net assets Change
2025-12-31$$1.06 B2.51%
2024-12-31$$1.03 B12.39%
2023-12-31$$0.92 B3.98%
2022-12-31$$0.88 B8.62%
2021-12-31$$0.81 B9.53%
2020-12-31$$0.74 B25.1%
2019-12-31$$0.59 B31.43%
2018-12-31$$0.45 B69.37%
2017-12-31$$0.26 B39.49%
2016-12-31$$0.19 B117.89%
2015-12-31$$88 M116.24%
2014-12-31$$40.69 M21.62%
2013-12-31$$33.46 M-41.87%
2012-12-31$$57.57 M509.66%
2011-12-31$$9.44 M-121.31%
2010-12-31$-$44.32 Million619.95%
2009-12-31$-$6.16 Million-8.76%
2008-12-31$-$6.75 Million

Net assets for similar companies or competitors

Company Net assets differencediff. Country
Johnson & Johnson
JNJ
$81.18 B 7,439.56%๐Ÿ‡บ๐Ÿ‡ธ USA
Abbott Laboratories
ABT
$52.70 B 4,794.22%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
$31.19 B 2,797.29%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
$20.10 B 1,766.83%๐Ÿ‡บ๐Ÿ‡ธ USA
United Therapeutics
UTHR
$5.90 B 448.02%๐Ÿ‡บ๐Ÿ‡ธ USA